The problem with post-FR valuation is that IVFH had roughly 7.5 million shares outstanding before it bought FD. As of Q3/2015, there were a bit under 24 million outstanding.
By the time they sell FD, it will have been five months since that report. Let's be generous and assume they only lost $1 million a month in Q4/2015 and Jan. and Feb. in 2016. So how many shares outstanding now? We'll find out in mid May when the Q1/2016 report is filed. Maybe sooner.
The good news is that the bleeding is going to stop. The bad news is that the potential liability for prior ownership will continue for many months following the sale.
News 
Market Data 
Discover 
